Hussman Strategic Advisors Inc. Takes $1.99 Million Position in Astrana Health, Inc. (NASDAQ:ASTH)

Hussman Strategic Advisors Inc. acquired a new position in Astrana Health, Inc. (NASDAQ:ASTH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 63,000 shares of the company’s stock, valued at approximately $1,986,000. Hussman Strategic Advisors Inc. owned approximately 0.11% of Astrana Health at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of ASTH. Nisa Investment Advisors LLC bought a new stake in Astrana Health in the third quarter worth $35,000. KBC Group NV bought a new stake in Astrana Health in the third quarter worth $70,000. Quarry LP bought a new stake in Astrana Health in the third quarter worth $77,000. Quest Partners LLC bought a new stake in Astrana Health in the third quarter worth $133,000. Finally, Paloma Partners Management Co acquired a new position in Astrana Health during the 3rd quarter worth $220,000. 52.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Truist Financial cut their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Macquarie raised shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $63.67.

Astrana Health Stock Up 0.6 %

Shares of ASTH opened at $39.13 on Thursday. The company has a 50-day simple moving average of $35.11 and a 200-day simple moving average of $45.12. The firm has a market capitalization of $2.20 billion, a P/E ratio of 30.10, a P/E/G ratio of 1.50 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health, Inc. has a 52 week low of $29.08 and a 52 week high of $63.20.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.